Drug repositioning from bench to bedside: Tumour remission by the antihelmintic drug mebendazole in refractory metastatic colon cancer

@article{Nygren2014DrugRF,
  title={Drug repositioning from bench to bedside: Tumour remission by the antihelmintic drug mebendazole in refractory metastatic colon cancer},
  author={P. Nygren and R. Larsson},
  journal={Acta Oncologica},
  year={2014},
  volume={53},
  pages={427 - 428}
}
Drug repositioning from bench to bedside : Tumour remission by the antihelmintic drug mebendazole in refractory metastatic colon cancer 
Drug Repositioning for Cancer Treatment : Novel Candidate Identification Strategies
Regardless of the enormous investments in cancer research and drug development, the proportion of approved drugs in oncology is low compared to other indications, and new avenues are needed. One atExpand
Flubendazole induces mitotic catastrophe and senescence in colon cancer cells in vitro
TLDR
The aim of present study was to elucidate the mechanisms of antiproliferative effect of FLU on colorectal cancer cells in vitro. Expand
Drug repurposing and relabeling for cancer therapy: Emerging benzimidazole antihelminthics with potent anticancer effects.
TLDR
The effective anticancer properties of mebendazole, albendAZole, and flubendazoles either alone or synergistically with frontline drugs, warrant their validation through controlled clinical trials to use them as promising avenues to anticancer therapy. Expand
Repositioning of Anthelmintic Drugs for the Treatment of Cancers of the Digestive System
TLDR
Compounds belonging to some classes of anthelmintics have shown pronounced anti-tumor activities and attracted particular attention due to their ability to target key oncogenic signal transduction pathways. Expand
Repurposing Drugs in Oncology (ReDO)—mebendazole as an anti-cancer agent
TLDR
It is proposed that mebendazole would synergise with a range of other drugs, including existing chemotherapeutics, and that further exploration of the potential of mebENDazole as an anti-cancer therapeutic is warranted. Expand
Repositioning of drugs for intervention in tumor progression and metastasis: Old drugs for new targets.
  • G. Mudduluru, W. Walther, +4 authors U. Stein
  • Medicine
  • Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy
  • 2016
TLDR
The repositioning of nonsteroidal anti-inflammatory drugs (NSAID), statins, anti-psychotic drugs,Anti-helminthic drugs and vitamin D as anti-tumor agents are discussed, which elucidate their therapeutic mechanisms which enable their rep positioning for cancer therapy and disruption of metastasis. Expand
Mebendazole as a Candidate for Drug Repurposing in Oncology: An Extensive Review of Current Literature
TLDR
In vitro studies suggest that MBZ inhibits a wide range of factors involved in tumor progression such as tubulin polymerization, angiogenesis, pro-survival pathways, matrix metalloproteinases, and multi-drug resistance protein transporters. Expand
Overcoming cancer therapeutic bottleneck by drug repurposing
TLDR
This review presents various promising repurposed non-oncology drugs for clinical cancer management and classify these candidates into their proposed administration for either mono- or drug combination therapy. Expand
Drug repurposing in cancer.
TLDR
An overview of promising candidates for drug repurposing in cancer is provided, as well as studies describing the biological mechanisms underlying their anti-neoplastic effects. Expand
A role for deferasirox as an anti-neoplastic and chemosensitising agent in gastrointestinal cancer
TLDR
This project aimed to demonstrate that a strategy to deplete tumour cells of iron using the licensed iron chelator Deferasirox was effective in the treatment of oesophageal and colorectal cancer. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 11 REFERENCES
Drug repositioning: identifying and developing new uses for existing drugs
TLDR
Repositioning existing drugs for new indications could deliver the productivity increases that the industry needs while shifting the locus of production to biotechnology companies. Expand
Mebendazole monotherapy and long-term disease control in metastatic adrenocortical carcinoma.
TLDR
Mebendazole may achieve long-term disease control of metastatic adrenocortical carcinoma and it is well tolerated and the associated adverse effects are minor. Expand
Mebendazole elicits a potent antitumor effect on human cancer cell lines both in vitro and in vivo.
TLDR
It is found that mebendazole (MZ), a derivative of benzimidazole, induces a dose- and time-dependent apoptotic response in human lung cancer cell lines and is effective in the treatment of cancer and other angiogenesis-dependent diseases. Expand
Evaluation of the planning target volume in the treatment of head and neck cancer with intensity-modulated radiotherapy: what is the appropriate expansion margin in the setting of daily image guidance?
TLDR
The use of 3-mm PTV expansion margins appears adequate and did not increase local-regional failures among patients treated with IMRT for head and neck cancer, demonstrating the safety of PTV reduction of less than 5 mm and support current protocols recommending this approach in the setting of daily IGRT. Expand
The dose to the parotid glands with IMRT for oropharyngeal tumors: the effect of reduction of positioning margins.
TLDR
Reducing the CTV-PTV margin by improving the patient position accuracy may lead to a significant reduction of NTCP for the IMRT treatment of the oropharyngeal tumors and lymph nodes level II. Expand
The impact of daily setup variations on head-and-neck intensity-modulated radiation therapy.
TLDR
The results of this study suggest that more rigorous immobilization techniques than conventional masking and routine patient setup tracking methodologies are important for the accurate monitoring and successful delivery of high-quality IMRT for H&N cancer. Expand
Cancer: the road to Amiens.
  • D. Stewart, R. Kurzrock
  • Medicine
  • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • 2009
TLDR
The Battle of Amiens was the opening phase of the Allied offensive that ultimately led to the end of World War I and provided an example of the effectiveness of shifting from stagnant trench warfare to mobile multifaceted warfare. Expand
The probability of correct target dosage: dose-population histograms for deriving treatment margins in radiotherapy.
TLDR
Dose-population histograms provide insight into the effects of geometrical deviations on a population of patients and use a dose-probability based approach to derive margin rules. Expand
Daily image guidance with cone-beam computed tomography for head-and-neck cancer intensity-modulated radiotherapy: a prospective study.
TLDR
The results of the study have shown that image-guided radiotherapy using CBCT for head-and-neck cancer is effective, and data suggest it allows a reduction in the clinical target volume to planning target volume margins by about 50%, which could facilitate future studies of dose escalation and/or improved toxicity reduction. Expand
Local setup errors in image-guided radiotherapy for head and neck cancer patients immobilized with a custom-made device.
TLDR
Evaluating the local positioning uncertainties during fractionated radiotherapy of head-and-neck cancer patients immobilized using a custom-made fixation device and discussing the effect of possible patient correction strategies for these uncertainties concluded that weighting of anatomic subregions to obtain the optimal correction vector should be investigated in the future. Expand
...
1
2
...